Non-ownership Filings
| Result of AGM | May. 22, 2025 |
| Application: FDA Breakthrough Therapy Designation | May. 02, 2025 |
| Notice of AGM | Apr. 29, 2025 |
| Publication of Annual Report | Apr. 25, 2025 |
| Promising Preliminary Results of Phase 1 Study | Apr. 11, 2025 |
| Placing to raise £250,000 | Mar. 18, 2025 |
| IB Expands Distribution with Blackford | Feb. 03, 2025 |
Ownership Update Filings
| Holding(s) in Company | Oct. 15, 2024 |
| Holding(s) in Company | Oct. 14, 2024 |
| PDMR dealing and TR1 announcement | Oct. 14, 2024 |
| Grant of Options | Mar. 05, 2024 |
| Holding(s) in Company | Mar. 01, 2024 |
| Holding(s) in Company | Mar. 01, 2024 |
| Holding(s) in Company | Jan. 22, 2024 |